Invesco’s STAAR Surgical STAA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.83M | Sell |
133,417
-15,610
| -10% | -$434K | ﹤0.01% | 2328 |
|
|
2026
Q1 | $2.79M | Sell |
149,027
-12,521
| -8% | -$239K | ﹤0.01% | 2406 |
|
|
2025
Q4 | $3.73M | Buy |
161,548
+10,652
| +7% | +$275K | ﹤0.01% | 2377 |
|
|
2025
Q3 | $4.05M | Buy |
150,896
+956
| +0.6% | +$22.8K | ﹤0.01% | 2323 |
|
|
2025
Q2 | $2.52M | Sell |
149,940
-77,380
| -34% | -$1.36M | ﹤0.01% | 2490 |
|
|
2025
Q1 | $4.01M | Buy |
227,320
+24,339
| +12% | +$488K | ﹤0.01% | 2263 |
|
|
2024
Q4 | $4.93M | Buy |
202,981
+13,714
| +7% | +$392K | ﹤0.01% | 2255 |
|
|
2024
Q3 | $7.03M | Buy |
189,267
+13,004
| +7% | +$485K | ﹤0.01% | 2027 |
|
|
2024
Q2 | $8.39M | Buy |
176,263
+20,447
| +13% | +$896K | ﹤0.01% | 1903 |
|
|
2024
Q1 | $5.96M | Buy |
155,816
+11,018
| +8% | +$358K | ﹤0.01% | 2114 |
|
|
2023
Q4 | $4.52M | Sell |
144,798
-20,863
| -13% | -$750K | ﹤0.01% | 2295 |
|
|
2023
Q3 | $6.66M | Buy |
165,661
+90,896
| +122% | +$4.26M | ﹤0.01% | 2040 |
|
|
2023
Q2 | $3.93M | Buy |
74,765
+804
| +1% | +$49K | ﹤0.01% | 2357 |
|
|
2023
Q1 | $4.73M | Buy |
73,961
+14,374
| +24% | +$938K | ﹤0.01% | 2245 |
|
|
2022
Q4 | $2.89M | Sell |
59,587
-24,128
| -29% | -$1.51M | ﹤0.01% | 2497 |
|
|
2022
Q3 | $5.91M | Sell |
83,715
-466
| -0.6% | -$39.9K | ﹤0.01% | 2138 |
|
|
2022
Q2 | $5.97M | Sell |
84,181
-2,555
| -3% | -$165K | ﹤0.01% | 2189 |
|
|
2022
Q1 | $6.93M | Sell |
86,736
-7,224
| -8% | -$538K | ﹤0.01% | 2193 |
|
|
2021
Q4 | $8.58M | Sell |
93,960
-306,572
| -77% | -$32.9M | ﹤0.01% | 2102 |
|
|
2021
Q3 | $51.5M | Sell |
400,532
-308,974
| -44% | -$43.2M | 0.01% | 1037 |
|
|
2021
Q2 | $108M | Buy |
709,506
+452,609
| +176% | +$59.6M | 0.03% | 805 |
|
|
2021
Q1 | $27.1M | Buy |
256,897
+241,464
| +1,565% | +$24.2M | 0.01% | 1361 |
|
|
2020
Q4 | $1.22M | Sell |
15,433
-33,031
| -68% | -$2.42M | ﹤0.01% | 2860 |
|
|
2020
Q3 | $2.74M | Buy |
48,464
+20
| +0% | +$1.08K | ﹤0.01% | 2339 |
|
|
2020
Q2 | $2.98M | Sell |
48,444
-16,265
| -25% | -$664K | ﹤0.01% | 2271 |
|
|
2020
Q1 | $2.09M | Buy |
64,709
+7,880
| +14% | +$266K | ﹤0.01% | 2372 |
|
|
2019
Q4 | $2M | Sell |
56,829
-21,193
| -27% | -$699K | ﹤0.01% | 2645 |
|
|
2019
Q3 | $2.01M | Buy |
78,022
+1,388
| +2% | +$42.2K | ﹤0.01% | 2634 |
|
|
2019
Q2 | $2.25M | Buy |
76,634
+5,171
| +7% | +$149K | ﹤0.01% | 2648 |
|
|
2019
Q1 | $2.44M | Buy |
71,463
+8,880
| +14% | +$314K | ﹤0.01% | 2483 |
|
|
2018
Q4 | $2M | Sell |
62,583
-262,421
| -81% | -$10.2M | ﹤0.01% | 2531 |
|
|
2018
Q3 | $15.6M | Buy |
325,004
+183,849
| +130% | +$7.53M | ﹤0.01% | 1439 |
|
|
2018
Q2 | $4.38M | Buy |
141,155
+57,123
| +68% | +$1.34M | ﹤0.01% | 2225 |
|
|
2018
Q1 | $1.24M | Buy |
+84,032
| New | +$1.31M | ﹤0.01% | 2915 |
|
|
2015
Q3 | – | Sell |
-1,827
| Closed | -$18K | – | 3973 |
|
|
2015
Q2 | $18K | Buy |
+1,827
| New | +$16.9K | ﹤0.01% | 4045 |
|
Other funds holding STAA
BC
MAP
YC
AIM
Invesco's STAA Position: Q2 2026 in Review
Invesco reduced its STAAR Surgical (STAA) stake by 10% in Q2 2026, selling an estimated $434K and leaving 133,417 shares worth $3.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2328.
Invesco first reported a position in STAA in Q2 2015 and has held it in 35 quarters since. The position peaked at $108M in Q2 2021. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.
- Invesco held 133,417 shares of STAAR Surgical worth $3.83M as of Q2 2026.
- Invesco sold 15,610 STAAR Surgical shares in Q2 2026, an estimated $434K.
- STAAR Surgical made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2328 holding.
- Invesco first reported a position in STAAR Surgical in Q2 2015 and has held it in 35 quarters since.
- Invesco's STAAR Surgical position peaked at $108M in Q2 2021.
- 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.